DRUG

PU-H71

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for PU-H71

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
EGFR pancreatic ductal adenocarcinoma 0.208 Mid novel signal none

Clinical trials

7 registered trials for PU-H71

Source: ClinicalTrials.gov